R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 51.88 CNY 1.63%
Market Cap: 5B CNY
Have any thoughts about
R&G PharmaStudies Co Ltd?
Write Note

R&G PharmaStudies Co Ltd
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

R&G PharmaStudies Co Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
R
R&G PharmaStudies Co Ltd
SZSE:301333
Non-Reccuring Items
-ÂĄ23.2k
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Non-Reccuring Items
-ÂĄ35.7m
CAGR 3-Years
-53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Non-Reccuring Items
-ÂĄ24.1m
CAGR 3-Years
-46%
CAGR 5-Years
-66%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Non-Reccuring Items
-ÂĄ234.4m
CAGR 3-Years
N/A
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Non-Reccuring Items
ÂĄ2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Non-Reccuring Items
-ÂĄ53.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

R&G PharmaStudies Co Ltd
Glance View

Market Cap
5B CNY
Industry
Life Sciences Tools & Services

R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. The company is headquartered in Beijing, Beijing and currently employs 1,926 full-time employees. The company went IPO on 2022-08-02. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.

Intrinsic Value
59.36 CNY
Undervaluation 13%
Intrinsic Value
Price
R

See Also

What is R&G PharmaStudies Co Ltd's Non-Reccuring Items?
Non-Reccuring Items
-23.2k CNY

Based on the financial report for Dec 31, 2023, R&G PharmaStudies Co Ltd's Non-Reccuring Items amounts to -23.2k CNY.

What is R&G PharmaStudies Co Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 3Y
19%

Over the last year, the Non-Reccuring Items growth was -42%. The average annual Non-Reccuring Items growth rates for R&G PharmaStudies Co Ltd have been 19% over the past three years .

Back to Top